-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
-
Summary
-
Eton Pharmaceuticals, Inc. quarterly and annual Amortization of Intangible Assets in USD history and change rate from 31 Dec 2019 to 31 Mar 2025.
- Eton Pharmaceuticals, Inc. Amortization of Intangible Assets for the quarter ending 31 Mar 2025 was $1,001,000, a 355% increase year-over-year.
- Eton Pharmaceuticals, Inc. Amortization of Intangible Assets for the twelve months ending 31 Mar 2025 was $1,877,000, a 126% increase year-over-year.
- Eton Pharmaceuticals, Inc. annual Amortization of Intangible Assets for 2024 was $1,096,000, a 39% increase from 2023.
- Eton Pharmaceuticals, Inc. annual Amortization of Intangible Assets for 2023 was $790,000, a 51% decline from 2022.
- Eton Pharmaceuticals, Inc. annual Amortization of Intangible Assets for 2022 was $1,617,000, a 693% increase from 2021.